Clinical Trials in Phoenix

Showing 7681-7700 of 16,646 trials

COMPLETEDPhase 2< 1 mile

Vidofludimus Calcium for Primary Sclerosing Cholangitis

NCT03722576

To examine the safety, tolerability, and efficacy of daily dosing with vidofludimus calcium over a 6-month period.

Primary Sclerosing Cholangitis

Elizabeth Carey18 participantsStarted Jun 2019

Phoenix, Arizona, United States • Tempe, Arizona, United States • Rochester, Minnesota, United States

COMPLETEDPhase 2< 1 mile

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

NCT03486912

This is a study of experimental medication BMS-986036 given to adults with Nonalcoholic Steatohepatitis (NASH; the buildup of fat and inflammation in the liver that is not caused by alcohol) and liver cirrhosis (liver damage characterized by normal liver tissue being replaced by scar tissue).

Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)+1 more

Bristol-Myers Squibb155 participantsStarted Jun 2018

Madison, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +88 more locations

Vidofludimus Calcium for Primary Sclerosing Cholangitis

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

Find Trials by Condition in Phoenix

Open-Label Safety Study of AXS-05 in Subjects With Depression

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour

Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke

Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD